-
Mashup Score: 60Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers - 2 month(s) ago
Communications Medicine – Barnett et al. explore the role of blood-based tumor mutation burden in predicting outcomes to immune checkpoint inhibitors in patients with advanced breast or prostate…
Source: www.nature.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 19“Farewell, my stomach”: a Portuguese family story - 7 month(s) ago
A Portuguese family shares their sorrows and hopes, deeply entangled with the double face of a gene.
Source: www.publico.ptCategories: General Medicine News, UrologyTweet-
Incredible short documentary of founder mutation CDH1 in Portugal and gastric cancer - https://t.co/IYGUz7Zs4h https://t.co/pSWuguZpi0 @myESMO @ASCO @neerajaiims https://t.co/LsUhhRnbzp
-
-
Mashup Score: 19“Farewell, my stomach”: a Portuguese family story - 7 month(s) ago
A Portuguese family shares their sorrows and hopes, deeply entangled with the double face of a gene.
Source: www.publico.ptCategories: General Medicine News, UrologyTweet-
Incredible short documentary of founder mutation CDH1 in Portugal and gastric cancer - https://t.co/IYGUz7Zs4h https://t.co/pSWuguZpi0 @myESMO @ASCO @neerajaiims https://t.co/LsUhhRnbzp
-
-
Mashup Score: 18“Farewell, my stomach”: a Portuguese family story - 7 month(s) ago
A Portuguese family shares their sorrows and hopes, deeply entangled with the double face of a gene.
Source: www.publico.ptCategories: General Medicine News, UrologyTweet-
Incredible short documentary of founder mutation CDH1 in Portugal and gastric cancer - https://t.co/IYGUz7Zs4h https://t.co/pSWuguZpi0 @myESMO @ASCO @neerajaiims https://t.co/LsUhhRnbzp
-
-
Mashup Score: 18“Farewell, my stomach”: a Portuguese family story - 7 month(s) ago
A Portuguese family shares their sorrows and hopes, deeply entangled with the double face of a gene.
Source: www.publico.ptCategories: General Medicine News, UrologyTweet-
Incredible short documentary of founder mutation CDH1 in Portugal and gastric cancer - https://t.co/IYGUz7Zs4h https://t.co/pSWuguZpi0 @myESMO @ASCO @neerajaiims https://t.co/LsUhhRnbzp
-
-
Mashup Score: 362024 ASCO Direct Hawaii | Total Health - 8 month(s) ago
This free oncology conference will showcase abstracts from highly-rated ASCO 2024 presentations, breaking down the key takeaways to directly impact patient care.
Source: www.totalhealthoncology.comCategories: General Medicine News, UrologyTweet-
Excited to join Total Health in partnership with HSCO and the University of Hawai'i Cancer Center as a speaker at their upcoming 2024 ASCO Direct Hawaii Conference! Register Free Today: https://t.co/kbgXJBG3xD @TotalHealthConf @OSSatACCC @UHCancerCenter https://t.co/nnZUtTQPz4
-
-
Mashup Score: 14Healthcare Unfiltered: ABIM and MOC: The Epic Debate With Richard Baron and Aaron Goodman on Apple Podcasts - 1 year(s) ago
Show Healthcare Unfiltered, Ep ABIM and MOC: The Epic Debate With Richard Baron and Aaron Goodman – Aug 8, 2023
Source: podcasts.apple.comCategories: Latest Headlines, Partners & KOLsTweet-
I’m thankful to everyone who has messaged me about today’s podcast - this podcast is on its way to be the most listened to podcast since I started 4 years ago. Clearly, TOP of MIND topic to all docs and stakeholders. @AaronGoodman33 MOC & ABIM. https://t.co/74FPoMUhAT
-
RT @chadinabhan: @abgutman The full episode is here https://t.co/74FPoMUhAT
-
RT @chadinabhan: @abgutman The full episode is here https://t.co/74FPoMUhAT
-
-
Mashup Score: 6FDA approves olaparib with abiraterone and prednisone - 2 year(s) ago
FDA approves olaparib with abiraterone and prednisone (or prednisolone) for BRCA-mutated metastatic castration-resistant prostate cancer
Categories: Latest Headlines, UrologyTweet-
And it’s finally out: FDA just approves olaparib+abiraterone for mCRPC pra with BRCA mut. #propel f/ ODAC recs. More news with #talapro2 #magnitude soon @FDAOncology ? @neerajaiims @AarmstrongDuke @DrChoueiri @GUONCGarciaJA @AarmstrongDuke @DrRanaMcKay https://t.co/0cmIbKj5ud
-
-
Mashup Score: 0Prior Authorization - 2 year(s) ago
Ask your lawmakers to protect patients’ timely access to care by streamlining prior authorization requirements in the Medicare Advantage program
Source: asco.quorum.usCategories: Latest Headlines, UrologyTweet-
I contacted my lawmakers about protecting patients' timely access to care. Join me! #ASCOAdvocacy https://t.co/TBTfDDS5yt
-
-
Mashup Score: 3NewsDetails - 2 year(s) ago
Contact Rachel Darwin, Senior Manager, Public Relations darwin@nccn.org, 2676226624 Four Early-Career Cancer Researchers Earn Prestigious Annual Award from NCCN Foundation National Comprehensive Cancer Network’s…
Source: NCCNCategories: Latest Headlines, UrologyTweet-
RT @NCCN: Four early-career cancer researchers earn prestigious annual award from NCCN Foundation. Learn more: https://t.co/UGZfk8kYtw #NCC…
-
Hot of the press: our recent collaboration showing blood-based TMB not good predictive to IO in “cold tumors” breast and prostate cancers @Nature @AlanBryce9 @TiansterZhang @bilenma @AarmstrongDuke @GuardantHealth https://t.co/61rzYdb8kW